You
are here: Home: CCU 2 | 2003: Faculty
Disclosures
FACULTY DISCLOSURES
As a provider accredited
by the ACCME, it is the policy of NL Communications Inc to
require the disclosure of any
significant financial interest or any other relationship
the sponsor or faculty members have with the manufacturer(s)
of any commercial product(s) discussed in an educational
presentation. The presenting faculty reported the following:
|
| Howard
S Hochster, MD |
Grants/Research Support: Sanofi-Synthelabo
Inc, Eli Lilly & Company, Bristol-Myers Squibb Company,
ImClone Systems Inc
Consultant: Sanofi-Synthelabo Inc, ImClone
Systems Inc, Bristol-Myers Squibb Company
Honorarium: Sanofi-Synthelabo Inc, ImClone
Systems Inc,
Bristol-Myers Squibb Company |
| James
L Abbruzzese, MD |
Grants/Research Support: Pharmacia
Corporation, Novartis Pharmaceuticals Corporation, Eli
Lilly & Company, Bristol-Myers Squibb Company, ImClone
Systems Inc
Consultant: Variagenics Inc, Millennium
Pharmaceuticals Inc
Honorarium: Pharmacia Corporation, Novartis
Pharmaceuticals Corporation, Eli Lilly&Company, Bristol-Myers
Squibb Company, ImClone Systems Inc, Variagenics Inc,
Millennium Pharmaceuticals Inc
Other Financial or Material Support: National
Cancer Institute |
Al B Benson, III, MD, FACP |
Grants/Research Support: National
Cancer Institute, Frontier Science & Technology Research
Foundation, University of Pittsburgh, Cancer Institute
of New Jersey, Taiho Pharmaceutical Co Ltd, Bristol-Myers
Squibb/Theradex, Matrix Pharmaceutical Inc, Glaxo Wellcome,
Merck & Company Inc, Pharmacia & Upjohn, Aventis
Pharmaceuticals Inc, Genetics Institute Inc, US Bioscience,
Novartis Pharmaceuticals Corporation, Searle Pharmaceutical
Company, Genentech Inc, ImClone Systems Inc, Sanofi-Synthelabo
Inc, Eli Lilly & Company, AstraZeneca Pharmaceuticals
LP
Consultant/Speakers’ Bureau: Matrix
Pharmaceuticals Advisory Board, US Bioscience Advisory
Board, Glaxo Wellcome Advisory Board, Cell Pathways Advisory
Board, AstraZeneca Advisory Board, Novartis Oncologists’ Advisory
Board, Aventis Advisory Board, ImClone Systems Inc, Vida
Healthcare Inc
Speakers’ Bureau: Pharmacia Corporation
Consultant: Pharmacia & Upjohn,
Abbott Laboratories, Searle Pharmaceutical Company, Bristol-Myers
Squibb Company, Sugen Inc, Intracel LLC, Genentech BioOncology,
Schering Plough |
| James
N Atkins, MD |
No financial interests or affiliations to disclose. |
This educational activity contains discussion of published
and/or investigational uses of agents that are not indicated
by the FDA. NL Communications Inc does not recommend the
use of any agent outside of the labeled indications. Please
refer to the official prescribing information for each product
for discussion of approved indications, contraindications
and warnings. The opinions expressed are those of the presenters
and are not to be construed as those of the publisher or
grantor.
|
